Contribution of EDHF and the role of potassium channels in the regulation of vascular tone

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Potassium channels in both endothelial and vascular smooth muscle play an important role in the regulation of vascular tone and are therefore potential targets for new drug development. Endothelial cell potassium channels, notably small conductance and intermediate conductance calcium-activated K channels (SKCa and IKCa, respectively), are of critical importance for the regulation of synthesis and, possibly, release of nitric oxide (NO) and prostacyclin (PGI2) as well as the elusive endothelium-derived hyperpolarizing factor (EDHF). EDHF may represent the "third" pathway for endothelium- dependent relaxation and, if a chemical mediator is involved, EDHF may represent a new class of K-channel openers. Of interest also is that endothelial cell dysfunction is a common feature of cardiovascular disease and this dysfunction is often associated with a decreased availability of endothelium-derived NO and, sometimes, an enhanced contribution of EDHF. This raises the question of the possibility that EDHF may play a pathophysiological function. A high degree of heterogeneity exists with respect to the pharmacological properties of EDHF and this may indicate that multiple EDHFs exist with some degree of vessel selectivity. Despite the heterogeneity in the properties of EDHF, a common feature is that a combination of two K-channel toxins, apamin and charybdotoxin, which target the SKCa and IKCa channels, respectively (charybdotoxin also inhibits large-conductance KCa, BKCa, and voltage-gated, KV channels). The requirement for both toxins for inhibiting EDHF is suggestive that a novel K channel may exist in the vasculature; however, to date the discovery of such a channel has remained elusive.

Original languageEnglish
Pages (from-to)81-89
Number of pages9
JournalDrug Development Research
Volume58
Issue number1
DOIs
Publication statusPublished - 1 Jan 2003
Externally publishedYes

Fingerprint

Charybdotoxin
Potassium Channels
Endothelial cells
Epoprostenol
Endothelium
Blood Vessels
Nitric Oxide
Apamin
Calcium-Activated Potassium Channels
Muscle
Availability
Electric potential
Pharmaceutical Preparations
Endothelial Cells
Vascular Smooth Muscle
Cardiovascular Diseases
Pharmacology
endothelium-dependent hyperpolarization factor

Keywords

  • Apamin
  • Charybdotoxin
  • Endothelium-derived hyperpolarizing factor
  • Potassium channels

ASJC Scopus subject areas

  • Drug Discovery
  • Organic Chemistry
  • Pharmacology

Cite this

Contribution of EDHF and the role of potassium channels in the regulation of vascular tone. / Ding, Hong; Triggle, Christopher.

In: Drug Development Research, Vol. 58, No. 1, 01.01.2003, p. 81-89.

Research output: Contribution to journalArticle

@article{6931632027674b9e89a153cf663a9be3,
title = "Contribution of EDHF and the role of potassium channels in the regulation of vascular tone",
abstract = "Potassium channels in both endothelial and vascular smooth muscle play an important role in the regulation of vascular tone and are therefore potential targets for new drug development. Endothelial cell potassium channels, notably small conductance and intermediate conductance calcium-activated K channels (SKCa and IKCa, respectively), are of critical importance for the regulation of synthesis and, possibly, release of nitric oxide (NO) and prostacyclin (PGI2) as well as the elusive endothelium-derived hyperpolarizing factor (EDHF). EDHF may represent the {"}third{"} pathway for endothelium- dependent relaxation and, if a chemical mediator is involved, EDHF may represent a new class of K-channel openers. Of interest also is that endothelial cell dysfunction is a common feature of cardiovascular disease and this dysfunction is often associated with a decreased availability of endothelium-derived NO and, sometimes, an enhanced contribution of EDHF. This raises the question of the possibility that EDHF may play a pathophysiological function. A high degree of heterogeneity exists with respect to the pharmacological properties of EDHF and this may indicate that multiple EDHFs exist with some degree of vessel selectivity. Despite the heterogeneity in the properties of EDHF, a common feature is that a combination of two K-channel toxins, apamin and charybdotoxin, which target the SKCa and IKCa channels, respectively (charybdotoxin also inhibits large-conductance KCa, BKCa, and voltage-gated, KV channels). The requirement for both toxins for inhibiting EDHF is suggestive that a novel K channel may exist in the vasculature; however, to date the discovery of such a channel has remained elusive.",
keywords = "Apamin, Charybdotoxin, Endothelium-derived hyperpolarizing factor, Potassium channels",
author = "Hong Ding and Christopher Triggle",
year = "2003",
month = "1",
day = "1",
doi = "10.1002/ddr.10135",
language = "English",
volume = "58",
pages = "81--89",
journal = "Drug Development Research",
issn = "0272-4391",
publisher = "John Wiley and Sons Inc.",
number = "1",

}

TY - JOUR

T1 - Contribution of EDHF and the role of potassium channels in the regulation of vascular tone

AU - Ding, Hong

AU - Triggle, Christopher

PY - 2003/1/1

Y1 - 2003/1/1

N2 - Potassium channels in both endothelial and vascular smooth muscle play an important role in the regulation of vascular tone and are therefore potential targets for new drug development. Endothelial cell potassium channels, notably small conductance and intermediate conductance calcium-activated K channels (SKCa and IKCa, respectively), are of critical importance for the regulation of synthesis and, possibly, release of nitric oxide (NO) and prostacyclin (PGI2) as well as the elusive endothelium-derived hyperpolarizing factor (EDHF). EDHF may represent the "third" pathway for endothelium- dependent relaxation and, if a chemical mediator is involved, EDHF may represent a new class of K-channel openers. Of interest also is that endothelial cell dysfunction is a common feature of cardiovascular disease and this dysfunction is often associated with a decreased availability of endothelium-derived NO and, sometimes, an enhanced contribution of EDHF. This raises the question of the possibility that EDHF may play a pathophysiological function. A high degree of heterogeneity exists with respect to the pharmacological properties of EDHF and this may indicate that multiple EDHFs exist with some degree of vessel selectivity. Despite the heterogeneity in the properties of EDHF, a common feature is that a combination of two K-channel toxins, apamin and charybdotoxin, which target the SKCa and IKCa channels, respectively (charybdotoxin also inhibits large-conductance KCa, BKCa, and voltage-gated, KV channels). The requirement for both toxins for inhibiting EDHF is suggestive that a novel K channel may exist in the vasculature; however, to date the discovery of such a channel has remained elusive.

AB - Potassium channels in both endothelial and vascular smooth muscle play an important role in the regulation of vascular tone and are therefore potential targets for new drug development. Endothelial cell potassium channels, notably small conductance and intermediate conductance calcium-activated K channels (SKCa and IKCa, respectively), are of critical importance for the regulation of synthesis and, possibly, release of nitric oxide (NO) and prostacyclin (PGI2) as well as the elusive endothelium-derived hyperpolarizing factor (EDHF). EDHF may represent the "third" pathway for endothelium- dependent relaxation and, if a chemical mediator is involved, EDHF may represent a new class of K-channel openers. Of interest also is that endothelial cell dysfunction is a common feature of cardiovascular disease and this dysfunction is often associated with a decreased availability of endothelium-derived NO and, sometimes, an enhanced contribution of EDHF. This raises the question of the possibility that EDHF may play a pathophysiological function. A high degree of heterogeneity exists with respect to the pharmacological properties of EDHF and this may indicate that multiple EDHFs exist with some degree of vessel selectivity. Despite the heterogeneity in the properties of EDHF, a common feature is that a combination of two K-channel toxins, apamin and charybdotoxin, which target the SKCa and IKCa channels, respectively (charybdotoxin also inhibits large-conductance KCa, BKCa, and voltage-gated, KV channels). The requirement for both toxins for inhibiting EDHF is suggestive that a novel K channel may exist in the vasculature; however, to date the discovery of such a channel has remained elusive.

KW - Apamin

KW - Charybdotoxin

KW - Endothelium-derived hyperpolarizing factor

KW - Potassium channels

UR - http://www.scopus.com/inward/record.url?scp=0037285558&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037285558&partnerID=8YFLogxK

U2 - 10.1002/ddr.10135

DO - 10.1002/ddr.10135

M3 - Article

AN - SCOPUS:0037285558

VL - 58

SP - 81

EP - 89

JO - Drug Development Research

JF - Drug Development Research

SN - 0272-4391

IS - 1

ER -